Global Botanical and Plant Derived Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Botanical and Plant Derived Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
Due to the COVID-19 pandemic, the global Botanical and Plant Derived Drugs market size was US$ 28140 million in 2024 and is forecast to a readjusted size of US$ 37100 million by 2034 with a CAGR of 3.6% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Tablets accounting for % of the Botanical and Plant Derived Drugs global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Botanical and Plant Derived Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Botanical and Plant Derived Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Botanical and Plant Derived Drugs market. Readers of the report can become informed about current and future trends of the global Botanical and Plant Derived Drugs market and how they will impact market growth during the forecast period.
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Segment by Type
Tablets
Capsules
Pills
Injections
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Botanical and Plant Derived Drugs in global and regional level.
Chapter 3Detailed analysis of Botanical and Plant Derived Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical and Plant Derived Drugs revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Due to the COVID-19 pandemic, the global Botanical and Plant Derived Drugs market size was US$ 28140 million in 2024 and is forecast to a readjusted size of US$ 37100 million by 2034 with a CAGR of 3.6% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Tablets accounting for % of the Botanical and Plant Derived Drugs global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Botanical and Plant Derived Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Botanical and Plant Derived Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Botanical and Plant Derived Drugs market. Readers of the report can become informed about current and future trends of the global Botanical and Plant Derived Drugs market and how they will impact market growth during the forecast period.
By Company
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Segment by Type
Tablets
Capsules
Pills
Injections
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Botanical and Plant Derived Drugs in global and regional level.
Chapter 3Detailed analysis of Botanical and Plant Derived Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical and Plant Derived Drugs revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices